Literature DB >> 6148810

Extra-adrenal and metastatic pheochromocytoma: the role of 131I meta-iodobenzylguanidine (131I MIBG) in localization and management.

N W Thompson, M D Allo, B Shapiro, J C Sisson, W Beierwaltes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6148810     DOI： 10.1007/bf01654948

Source DB:  PubMed          Journal:  World J Surg        ISSN： 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  9 in total

1.  Adrenal medullary disease in multiple endocrine neoplasia, type 2: pheochromocytoma and its precursors.

Authors:  J A Carney; G W Sizemore; S G Sheps
Journal:  Am J Clin Pathol       Date:  1976-08       Impact factor: 2.493

2.  Unilateral versus bilateral adrenalectomy in multiple endocrine neoplasia IIA.

Authors:  S Tibblin; J F Dymling; S Ingemansson; M Telenius-Berg
Journal:  World J Surg       Date:  1983-03       Impact factor: 3.352

3.  Treatment of malignant pheochromocytoma.

Authors:  H Drasin
Journal:  West J Med       Date:  1978-02

4.  The triad of gastric epithelioid leiomyosarcoma, pulmonary chondroma, and functioning extra-adrenal paraganglioma: a five-year review.

Authors:  J A Carney
Journal:  Medicine (Baltimore)       Date:  1983-05       Impact factor: 1.889

5.  Extra-adrenal intrathoracic functioning paraganglioma (pheochromocytoma) in childhood.

Authors:  D J Hodgkinson; R L Telander; S G Sheps; G S Gilchrist; J K Crowe
Journal:  Mayo Clin Proc       Date:  1980-04       Impact factor: 7.616

6.  Attempted treatment of inoperable pheochromocytoma with streptozocin.

Authors:  B P Hamilton; I E Cheikh; L E Rivera
Journal:  Arch Intern Med       Date:  1977-06

7.  Radiolabeled adrenergi neuron-blocking agents: adrenomedullary imaging with [131I]iodobenzylguanidine.

Authors:  D M Wieland; J Wu; L E Brown; T J Mangner; D P Swanson; W H Beierwaltes
Journal:  J Nucl Med       Date:  1980-04       Impact factor: 10.057

8.  Spectrum of pheochromocytoma in multiple endocrine neoplasia. A scintigraphic portrayal using 131I-metaiodobenzylguanidine.

Authors:  T W Valk; M S Frager; M D Gross; J C Sisson; D M Wieland; D P Swanson; T J Mangner; W H Beierwaltes
Journal:  Ann Intern Med       Date:  1981-06       Impact factor: 25.391

9.  Scintigraphic localization of pheochromocytoma.

Authors:  J C Sisson; M S Frager; T W Valk; M D Gross; D P Swanson; D M Wieland; M C Tobes; W H Beierwaltes; N W Thompson
Journal:  N Engl J Med       Date:  1981-07-02       Impact factor: 91.245
  9 in total
  6 in total

Review 1.  Diagnostic problems in pheochromocytoma.

Authors:  M Mannelli
Journal:  J Endocrinol Invest       Date:  1989-11       Impact factor: 4.256

2.  Spectrum of pheochromocytoma in the 131I-MIBG era.

Authors:  P S Cheung; N W Thompson; C F Dmuchowski; J C Sisson
Journal:  World J Surg       Date:  1988-08       Impact factor: 3.352

Review 3.  The treatment of malignant pheochromocytoma with iodine-131 metaiodobenzylguanidine (131I-MIBG): a comprehensive review of 116 reported patients.

Authors:  K C Loh; P A Fitzgerald; K K Matthay; P P Yeo; D C Price
Journal:  J Endocrinol Invest       Date:  1997-12       Impact factor: 4.256

4.  Advanced gastric carcinoma combined with extra-adrenal pheochromocytoma resected after three courses of S-1 and cisplatin as neoadjuvant chemotherapy: report of a case.

Authors:  Hiroki Sunagawa; Susumu Inamine; Hisamitsu Zaha; Masanori Takeshima; Michio Miyata
Journal:  Surg Today       Date:  2008-04-30       Impact factor: 2.549

5.  High incidence of malignant pheochromocytoma in a surgical unit. 26 cases out of 100 patients operated from 1971 to 1991.

Authors:  C Proye; M Vix; A Goropoulos; P Kerlo; M Lecomte-Houcke
Journal:  J Endocrinol Invest       Date:  1992-10       Impact factor: 4.256

6.  Phaeochromocytoma: report of three cases.

Authors:  D Lewis; N Dalton; S Rigden
Journal:  Pediatr Nephrol       Date:  1987-01       Impact factor: 3.714
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.